Loading insider details...
Latest Form 4 (Nov 4, 2026): Grant/Award of 1,000,000 ESLA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Estrella Immunopharma, Inc. (ESLA) | Grant/Award | 1,000,000 | n/a |